Eye Movement Desensitization and Reprocessing (EMDR) to Treat Chronic Pruritus
Status
Conditions
Treatments
Details and patient eligibility
About
Pruritus is a common symptom of numerous dermatological and non-dermatological conditions. Current treatments for chronic pruritus (CP) are often not fully effective and may have burdensome side effects. Recently, the trauma exposure technique Eye Movement Desensitization and Reprocessing (EMDR) that is recommended as first line treatment for posttraumatic stress disorder has been reported to be also effective in the treatment of CP in anecdotal clinical case observations. However, to the best of the investigator's knowledge, the efficacy of EMDR in CP has not yet been systematically explored. This study aims at addressing this unmet need in a prospective pilot study comparing EMDR versus treatment as usual (TAU).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Provided written informed consent
- Age 18 to 75 years
- Skindex-29 (questionnaire) symptoms subscale ≥42
- Confirmed diagnosis CP
- Itch intensity of min. ≥ 4 on the 0-10 numerical rating scale within the last 7 days
- Stable course of treatment in the two weeks prior to the study
Exclusion criteria
- Inability to follow the procedures of the study, e.g. due to language problems, severe psychiatric disorders such as delusional disorder, suicidality or dementia.
- Patients on phototherapy
- Acute attacks of an autoimmune disease such as Crohn's disease
- Serious cardiac disease
Trial design
Primary purpose
Allocation
Interventional model
Masking
30 participants in 2 patient groups
Trial contacts and locations
Loading...
Central trial contact
Chrysovalandis Schwale, Dr.; Rainer Schaefert, Prof.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal